RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
Interchangeable Biosimilars Market revenue to hit USD 65 Billion by 2035, says Research Nester
September 11, 2023 07:00 ET
|
Research Nester
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The global Interchangeable Biosimilars market size is slated to expand at ~ 20 % CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Point of Care Diagnostics Market is Expected to Reach $75.5 billion | MarketsandMarkets.
August 30, 2023 09:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 30, 2023 (GLOBE NEWSWIRE) -- In the near future, the Point of Care Diagnostics industry is poised to undergo transformative advancements, revolutionizing healthcare by enabling rapid,...
Patient-Focused Next Generation Home Blood Test for Cardiometabolic Health Now Available to Consumers
August 28, 2023 12:08 ET
|
CardioMetaboliQ LLC
—An alarming 93 percent of US adults have less than optimal cardiometabolic health1 and many are completely unaware of their risk— —New test provides end-to-end cardiometabolic health solution, with...
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
August 28, 2023 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
August 28, 2023 06:35 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
[Latest] Global Recombinant Human Insulin Market Size/Share Worth USD 55.99 Billion by 2032 at a 8.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 25, 2023 16:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Recombinant Human Insulin Market Size, Trends and Insights By Product (Regular...
[Latest] Global Alginate Dressings Market Size/Share Worth USD 1,521.2 Million by 2032 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 15, 2023 02:00 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Alginate Dressings Market Size, Trends and Insights By Grade (Industrial Grade,...
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
August 10, 2023 16:05 ET
|
Structure Therapeutics Inc.
Completed enrollment in 12-week Phase 2a study of oral GLP-1 receptor agonist, GSBR-1290 Topline data from Phase 2a and Phase 1b multiple ascending dose study of GSBR-1290 expected in latter half of...
Rani Therapeutics to Participate in August Investor Conferences
August 04, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...